eFFECTOR Therapeutics Inc
Change company Symbol lookup
Select an option...
EFTR eFFECTOR Therapeutics Inc
EEX Emerald Holding Inc
JPM-L JPMorgan Chase & Co
SBFM Sunshine Biopharma Inc
SEKEY Seiko Epson Corp
PXMD PaxMedica Inc
CDT Conduit Pharmaceuticals Inc
FUSN Fusion Pharmaceuticals Inc
RDUS Schnitzer Steel Industries Inc
ALEC Alector Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of oncology drugs, such as selective translation regulator inhibitors (STRIs). The Company uses a selective translation regulation technology platform to internally discover a portfolio of small molecule STRI product candidates. Its product candidates target the eIF4F complex and its activating kinase, MNK. The Company’s lead product candidate, tomivosertib, is an inhibitor of MNK, and is being evaluated in combination with KEYTRUDA (pembrolizumab), an FDA-approved inhibitor of programmed cell death protein 1 (PD-1) in a randomized Phase 2b clinical trial in patients with metastatic non-small cell lung cancer (NSCLC). Its second product candidate, zotatifin, is an inhibitor of eIF4A, a component of the eIF4F complex, and is being evaluated in a Phase 1/2 clinical trial in patients with certain solid tumors. Its third program is focused on developing inhibitors of eIF4E.

Postmarket

Last Trade
Delayed
$0.52
Change Since Close

Change Since Close

Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.

0.005 (0.97%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$0.515
Day's Change
0.0002 (0.04%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
0.52
Day's Low
0.483
Volume
(Light)
Volume:
118,139

10-day average volume:
481,837
118,139
Historical quotes & splits
  • Prev Close
    0.5148
  • Today's Open
    0.5185
  • Day's Range
    0.483-0.52
  • Avg Vol (10-day)
    481.8K
  • Last (time)
    4:00p ET 09/25/23
  • Last (size)
    1
  • 52-Wk Range
    0.3378 - 1.48
    LowHigh
  • % Above Low

    % Above Low

    The current share price compared to the 52-week low.

    (03/30/23 - 06/06/23)
    52.46%
  • Historical Volatility

    Historical Volatility

    The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued.

    117.5%
  • Market Cap
    31.8M
  • Shares Outstanding
    61.8M
  • EPS (TTM, GAAP)

    EPS (TTM, GAAP)

    GAAP EPS (TTM) refers to a company's earnings per share (EPS) for the trailing twelve-month (TTM) period. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.

    GAAP vs. Non-GAAP Earnings

    TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.

    -0.87
  • P/E Ratio (TTM, GAAP)

    P/E Ratio (TTM, GAAP)

    GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months.

    GAAP vs. Non-GAAP Earnings

    TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.

    --
  • Annual Dividend/Yield

    Annual Dividend/Yield

    Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used. If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Annual Dividend/yield calculations do not guarantee or imply future payment of dividends.

    No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • Beta

    Beta

    The measure of a security's volatility in relation to the S&P 500. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.

    --
  • % Held by Institutions

    % Held by Institutions

    Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.

    44.66
  • Short Interest

    Short Interest

    The number of shares of a security that have been sold short by investors. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis.

    (% of float 08/31/23)
    1.56

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.

3rd Party Research Disclosure